BMY
Bristol-Myers Squibb Company$57.62-1.61% 1D· price as of Jun 30, 8:32 PM+23.52% over 1Y
Compare:BMY
Mkt Cap
$117.7B
P/E
16.1×
Fwd P/E
9.3×
PEG
1.49
P/B
5.9×
P/S
2.4×
EV/EBITDA
8.1×
Beta
0.24
Div Yield
4.3%
Payout
70.0%
ROE
38.7%
Net Margin
15.0%
Short % Flt
1.9%
Inst. Own
83.8%
52-wk low $42.52$57.6252-wk high $62.89
+35.5% above low-8.4% from high
Seasonality — avg monthly return
Strongest Feb 3.1% · weakest Apr -6.4%Jan
+0.9
Feb
+3.1
Mar
+2.7
Apr
-6.4
May
-2.3
Jun
+0.4
Jul
+0.5
Aug
+0.6
Sep
-2.5
Oct
+1.3
Nov
+0.9
Dec
+3.0
Average month-over-month return per calendar month over the available history (~5 yrs); hover for the share of positive months. Past seasonality isn't predictive.
Ask AI about Bristol-Myers Squibb Company
Gemini · web searchSearches the live web for current news & events plus this company's financials — and you can keep asking follow-up questions.
BMY — recent news
Loading headlines…
Quality scorecard
vs Pharmaceuticals · 7 peers · percentile rank
53 / 100
Average
ROIC16.3%
50
ROE38.2%
67
Gross margin71.1%
33
Operating margin28.5%
50
FCF yield10.9%
100
Net debt / EBITDA2.4×
17
Percentile vs 7 Pharmaceuticals peers — higher = better (leverage inverted: less debt ranks higher). The faint tick is the peer median; the score is the average percentile. Annual fundamentals.